Warren Averett Asset Management, LLC Crispr Therapeutics Ag Transaction History
Warren Averett Asset Management, LLC
- $5.05 Billion
- Q2 2024
A detailed history of Warren Averett Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 17,485 shares of CRSP stock, worth $793,294. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,485
Previous 9,081
92.54%
Holding current value
$793,294
Previous $618,000
52.75%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$357 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$353 Million3.82% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$143 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$143 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$126 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.54B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....